Director Global Market Access Oncology Early Assets/Business Development

Bristol Myers Squibb • Princeton, NJ

2d • $196,390 - $237,982 • Hybrid

About The Position

The Director, Global Market Access Oncology Early Assets & Business Development, will provide value, access, and pricing considerations in a systematic way into the product development governance process to help maximize the value of the BMS oncology portfolio and life cycle management. Reporting to the Executive Director, Oncology Market Access Strategy Integration, Early Assets & Business Development, the Director will lead the development of early market access strategies within assigned oncology asset(s) or sub-portfolio, and relevant business development activities. Key activities include providing strategic access input into the governance process to help determine where to play and how to win, particularly in the context of evolving drug pricing reforms and a complex market access environment with high levels of uncertainty.

Requirements

• Undergraduate degree required; MBA / MPH / PharmD or relevant post-graduate degree preferred.
• Minimum of 8+ years of Market Access / Commercial experience with a strong track record in market access strategy, pricing, and/or HEOR in global and/or US markets.
• Solid understanding of the current and emerging Market Access environment in oncology/hematology.
• Good working knowledge of the drug development & commercialization process, HTA assessment methodologies, global reimbursement environment, and regulatory requirements, including an understanding of payers and their perspective in key markets.
• Scientific background, preferably within oncology/hematology, supporting the assessment of trial design impact on payer strategies and the ability to partner with clinical development or medical affairs to help identify relevant clinical endpoints and outcomes research needs in early phases of clinical trial development.
• Demonstrated ability to contribute to Market Access strategic scenarios and to work effectively within cross-functional teams, with or without formal authority.
• Proven ability to articulate and support the translation of scientific/clinical value into economic value.
• Demonstration of all BMS Values.

Responsibilities

• Lead early market access strategy for assigned pipeline oncology compounds/indications, partnering closely with clinical development, early commercialization, and cross functional stakeholders, and represent MAx on relevant Clinical Development Team / Global Program Team where relevant.
• Inform the future access strategy for new compounds by helping assess clinical development strategies; contribute to the evidence generation plan and mitigation activities to address key market access and pricing opportunities and challenges.
• Provide oncology MAx input on Business Development requests from early commercialization and M&A/BD&L to assess access and pricing considerations and inform valuation, and represent MAx on the Valuation Core Team as needed.
• Lead above asset projects and workstreams to continue to evolve the oncology MAx expertise and capabilities for Early Assets and BD.
• Monitor the evolving external environment and synthesize input to inform Market Access strategies, ensuring access and value considerations (e.g., relevant endpoints, comparator, dosing, study population, subpopulation of interest) are reflected in protocol design, in collaboration with the cross-functional team (PASL, Pricing, HEOR, Medical & Local Markets).
• Partner with cross-functional Market Access teams and extended teams (Commercial, Clinical Development, Business Development, Forecasting, etc.) as well as relevant individual market stakeholders to help optimally position BMS products for success in an increasingly challenging and evolving access landscape.

Benefits

• Health Coverage: Medical, pharmacy, dental, and vision care.
• Wellbeing Support: Programs such as BMS Well-Being Account, BMS Living Life Better, and Employee Assistance Programs (EAP).
• Financial Well-being and Protection: 401(k) plan, short- and long-term disability, life insurance, accident insurance, supplemental health insurance, business travel protection, personal liability protection, identity theft benefit, legal support, and survivor support.
• Work-life benefits include: Paid Time Off
• US Exempt Employees: flexible time off (unlimited, with manager approval, 11 paid national holidays (not applicable to employees in Phoenix, AZ, Puerto Rico or Rayzebio employees)
• Phoenix, AZ, Puerto Rico and Rayzebio Exempt, Non-Exempt, Hourly Employees: 160 hours annual paid vacation for new hires with manager approval, 11 national holidays, and 3 optional holidays
• Based on eligibility, additional time off for employees may include unlimited paid sick time, up to 2 paid volunteer days per year, summer hours flexibility, leaves of absence for medical, personal, parental, caregiver, bereavement, and military needs and an annual Global Shutdown between Christmas and New Years Day.
• All global employees full and part-time who are actively employed at and paid directly by BMS at the end of the calendar year are eligible to take advantage of the Global Shutdown.
• Eligibility Disclosure: The summer hours program is for United States (U.S.) office-based employees due to the unique nature of their work. Summer hours are generally not available for field sales and manufacturing operations and may also be limited for the capability centers. Employees in remote-by-design or lab-based roles may be eligible for summer hours, depending on the nature of their work, and should discuss eligibility with their manager. Employees covered under a collective bargaining agreement should consult that document to determine if they are eligible. Contractors, leased workers and other service providers are not eligible to participate in the program.

What This Job Offers

• Job Type: Full-time
• Career Level: Director